The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial.
about
The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The effect of empagliflozin on ...... ded, placebo-controlled trial.
@en
type
label
The effect of empagliflozin on ...... ded, placebo-controlled trial.
@en
prefLabel
The effect of empagliflozin on ...... ded, placebo-controlled trial.
@en
P2093
P2860
P1433
P1476
The effect of empagliflozin on ...... ded, placebo-controlled trial.
@en
P2093
Emil List Larsen
Filip Krag Knop
Jørgen Rungby
Laura Kofoed Kjær
Vanja Cejvanovic
P2860
P304
P356
10.1136/BMJOPEN-2016-014728
P577
2017-05-09T00:00:00Z